The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs
- 1 March 2004
- journal article
- research article
- Published by Elsevier in Epilepsy Research
- Vol. 59 (1) , 13-24
- https://doi.org/10.1016/j.eplepsyres.2003.12.011
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on kindling acquisition and expressionEpilepsy Research, 2004
- Conantokin G Is an NR2B-Selective Competitive Antagonist ofN-Methyl-d-aspartate ReceptorsMolecular Pharmacology, 2000
- Molecular Dissection of Native Mammalian Forebrain NMDA Receptors Containing the NR1 C2 Exon: Direct Demonstration of NMDA Receptors Comprising NR1, NR2A, and NR2B Subunits Within the Same ComplexJournal of Neurochemistry, 1997
- Relationship between N-Methyl-D-aspartate Receptor NR1 Splice Variants and NR2 SubunitsJournal of Biological Chemistry, 1996
- A critical period for long-term potentiation at thalamocortical synapsesNature, 1995
- The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit compositionJournal of Neuroscience, 1994
- N-Methyl-D-aspartate receptors are clustered and immobilized on dendrites of living cortical neurons.Proceedings of the National Academy of Sciences, 1993
- Activity-Dependent Decrease in NMDA Receptor Responses During Development of the Visual CortexScience, 1992
- A kinetic analysis of the modulation of N‐methyl‐D‐aspartic acid receptors by glycine in mouse cultured hippocampal neurones.The Journal of Physiology, 1990
- Whole cell recording from neurons in slices of reptilian and mammalian cerebral cortexJournal of Neuroscience Methods, 1989